Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling
Nutrients · 2024
DOI: 10.3390/nu16091257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Matteo Nadile und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. Hauptthemen laut MEDLINE: Abietanes, Prostatic Neoplasms, Cell Proliferation, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Prostate Cancer Fight Foundation/Ride For Dad (PCFF/RFD), Ontario Graduate Scholarship (OGS).
Abstract (Originalsprache)
Prostate cancer, accounting for 375,304 deaths in 2020, is the second most prevalent cancer in men worldwide. While many treatments exist for prostate cancer, novel therapeutic agents with higher efficacy are needed to target aggressive and hormone-resistant forms of prostate cancer, while sparing healthy cells. Plant-derived chemotherapy drugs such as docetaxel and paclitaxel have been established to treat cancers including prostate cancer. Carnosic acid (CA), a phenolic diterpene found in the herb rosemary (Rosmarinus officinalis) has been shown to have anticancer properties but its effects in prostate cancer and its mechanisms of action have not been examined. CA dose-dependently inhibited PC-3 and LNCaP prostate cancer cell survival and proliferation (IC50: 64, 21 µM, respectively). Furthermore, CA decreased phosphorylation/activation of Akt, mTOR, and p70 S6K. A notable increase in phosphorylation/activation of AMP-activated kinase (AMPK), acetyl-CoA carboxylase (ACC) and its upstream regulator sestrin-2 was seen with CA treatment. Our data indicate that CA inhibits AKT-mTORC1-p70S6K and activates Sestrin-2-AMPK signaling leading to a decrease in survival and proliferation. The use of inhibitors and small RNA interference (siRNA) approaches should be employed, in future studies, to elucidate the mechanisms involved in carnosic acid’s inhibitory effects of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada.
- Centre for Bone and Muscle Health, Brock University, St. Catharines, ON L2S 3A1, Canada.
ORCID-Profile: Matteo Nadile, Newman Siu Kwan Sze, Val A Fajardo
Förderung
- Canadian Prostate Cancer Fight Foundation/Ride For Dad (PCFF/RFD)
- Ontario Graduate Scholarship (OGS)
Zitieren
APA
Nadile, M., Sze, N. S. K., Fajardo, V. A., & Tsiani, E. (2024). Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling. Nutrients. https://doi.org/10.3390/nu16091257
Vancouver
Nadile M, Sze NSK, Fajardo VA, Tsiani E. Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling. Nutrients. 2024. doi:10.3390/nu16091257
BibTeX
@article{Nadile2024,
author = {Nadile, Matteo and Sze, Newman Siu Kwan and Fajardo, Val A and Tsiani, Evangelia},
title = {Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16091257}
}
EUVIMED